We are live on ! Find out more
DOVA

Dova Pharmaceuticals, Inc. Common Stock
DOVA

Delisted

DOVA was delisted on the 11th of November, 2019.

Back to rankings

Fund managers haven’t disclosed any holdings of DOVA yet.

DOVA Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Dova Pharmaceuticals, Inc. Common Stock (DOVA) for Q4 2019, worth a combined $0 — down 100% from $278M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DOVA and 0 opened new positions — a net loss of 72 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $104M sold.

  • 0 institutional investors held Dova Pharmaceuticals, Inc. Common Stock (DOVA) as of Q4 2019, down from 72 in Q3 2019.
  • Funds reported $0 of Dova Pharmaceuticals, Inc. Common Stock stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Dova Pharmaceuticals, Inc. Common Stock positions in Q4 2019 and 72 closed out, a net change of -72 holders.
  • The largest Dova Pharmaceuticals, Inc. Common Stock seller in Q4 2019 was Perceptive Advisors, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2019.